Transplantation of pancreatic islets to adrenal gland is promoted by agonists of growth-hormone-releasing hormone

Schubert U.; Schmid J.; Lehmann S.Zhang X.Y.Morawietz H.Block N.L.Kanczkowski W.Schally A.V.Bornstein S.R.Ludwig B.

首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Transplantation of pancreatic islets to adrenal gland is promoted by agonists of growth-hormone-releasing hormone

【24h】

Transplantation of pancreatic islets to adrenal gland is promoted by agonists of growth-hormone-releasing hormone

机译：Transplantation of pancreatic islets to adrenal gland is promoted by agonists of growth-hormone-releasing hormone

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相关主题

摘要

Here, we evaluate an alternative approach of preconditioning pancreatic islets before transplantation using a potent agonist of growth-hormone-releasing hormone (GHRH) to promote islet viability and function, and we explore the adrenal gland as an alternative transplantation site for islet engraftment. The endocrine microenvironment of the adrenal represents a promising nichewith the unique advantages of exceptional high oxygen tension and local antiinflammatory and immunosuppressive properties. GHRH agonists have been shown to promote islet graft survival and function, which may help to reduce the islet mass necessary to reverse diabetes. In the present study, themost potent GHRH agonist MR403 was tested on insulinoma cells, isolated rat islets, and adrenal β-cell cocultures in vitro. GHRH receptor is expressed on both adrenal cells and islets. MR403 caused a significant increase in cell viability and proliferation and revealed an antiapoptotic effect on insulinoma cells. Viability of rat islets was increased after treatment with the agonist and in coculture with adrenal cells. Rat islets were transplanted into diabetic mice to the intraadrenal transplant site and compared with the classical transplants underneath the kidney capsule. Graft function and integration were tested by metabolic follow-up and immunohistochemical staining of intraadrenal grafts. A rapid decrease occurred in blood glucose levels in both models, and all animals reached normoglycemiawithin the first days after transplantation. Our studies demonstrated that the adrenal may be an attractive site for islet transplantation and that GHRH analogs might allow reduction of the islet mass needed to reverse a diabetic status.

著录项

来源
《Proceedings of the National Academy of Sciences of the United States of America》 |2013年第6期|2288-2293|共6页
作者
Schubert U.; Schmid J.; Lehmann S.Zhang X.Y.Morawietz H.Block N.L.Kanczkowski W.Schally A.V.Bornstein S.R.Ludwig B.;
展开▼
作者单位

Department of Medicine III, University Hospital Carl Gustav Carus, 01307 Dresden, Germany;

Division of Endocrinology and Hematology-Oncology, Department of Medicine and Department of Pathology, University of Miami Miller School of Medicine, Miami, FL 33136, United States;

展开▼
收录信息美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
原文格式 PDF
正文语种英语
中图分类自然科学总论;
关键词
β-Cell replacement; Regenerative therapy; Type 1 diabetes mellitus;

Transplantation of pancreatic islets to adrenal gland is promoted by agonists of growth-hormone-releasing hormone

摘要

著录项

相关主题

期刊订阅